Center for Advancing Risk Assessment Science and Policy (ARASP)

ARASP Comments on TCEQ 2015 Position Paper "Approaches to Derive Odor-Based Values" and Proposed Odor ESL List
July 2015

ARASP Comments on the 2015 Revision of the TCEQ Guidelines to Develop Toxicity Factors
July 2015

ARASP Adds to Industry Coalition Comments on EPA’s Work Plan Chemical Problem Formulation and Initial Assessment on 1,4-Dioxane:

• Industry Comments
  June 2015

• ARASP Comments
  June 2015

ARASP Comments on CPSC Proposed Rulemaking for the Prohibition of Children’s Toys and Child Care Articles Containing Specified Phthalates
April 2015

ARASP Comments on TCEQ 24-hour Inhalation Reference Values Whitepaper
May 2014

ACC ARASP Comments on Proposed Revision to NIOSH Carcinogen Policy
February 2014

ACC ARASP Comments on EPA NexGen Draft Report
January 2014

ACC ARASP on EtO and BaP for Dec 2013 IRIS Meeting
December 2013

ARASP Written Comments to CAAC Committee
August 2013

ARASP Written Comments on the Draft OHAT Approach and BPA and PFOA/PFOS Protocols for Systematic Review and Evidence Integration
June 2013

ARASP Written Comments on IRIS Handbook
June 2013

ARASP Written Comments to EPA on Systematic Review Workshop
May 2013

ARASP Oral Comments to EPA CAAC
April 2013

ARASP Comments to NAS IRIS Review Committee
September 2012

ARASP Comments on EPA Framework for Human Health Risk Assessment
September 2012

ARASP Submits Comments on EPA’s Draft Ammonia IRIS Assessment
August 6, 2012

ARASP Submits Comments on EPA’s External Review Draft of “A Framework for Human Health Risk Assessment to Inform Decision Making”
September 28, 2012

ARASP Comments on TCEQ Guidelines to Develop Toxicity Factors (RG-442)
June 2012

ARASP Submits Comments on EPA Report Regarding Lymphohematopoietic Cancers
January 24, 2011